| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6827341 | Schizophrenia Research | 2011 | 5 Pages |
Abstract
As currently defined, remission appears to be a very difficult therapeutic target to attain and maintain in chronic schizophrenia and may differ by antipsychotic medication. Pragmatically, remission gradients may be effectively studied by applying modified duration and symptom criteria.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Stephen Z. Levine, Jonathan Rabinowitz, Haya Ascher-Svanum, Douglas E. Faries, Anthony H. Lawson,